U.S. regulators approve pill to track patients
WASHINGTON — U.S. regulators have approved the first drug with a sensor that can track whether patients have taken their medicine.
The Abilify pill was first approved by the Food and Drug Administration in 2002 to treat schizophrenia, and the sensor technology was approved for marketing in 2012. The FDA said in a statement Monday that the digitally-enhanced medication “works by sending a message from the pill’s sensor to a wearable patch.” Abilify MyCite was developed by Otsuka Pharmaceutical Co. and the sensor was created by Proteus Digital Health.
While the system can track doses, it hasn’t been shown to improve patient compliance, the FDA said. Patients can track their dosage on their smartphone and allow their doctors or caregivers to access the information through a website.